- Home
- UAMY vs ARTV Comparison
UAMY vs ARTV Comparison
Compare UAMY & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- ARTV
- Stock Information
- Founded
- UAMY 1968
- ARTV 2019
- Country
- UAMY United States
- ARTV United States
- Employees
- UAMY N/A
- ARTV N/A
- Industry
- UAMY Metal Fabrications
- ARTV
- Sector
- UAMY Industrials
- ARTV
- Exchange
- UAMY Nasdaq
- ARTV NYSE
- Market Cap
- UAMY 251.9M
- ARTV 61.9M
- IPO Year
- UAMY N/A
- ARTV 2024
- Fundamental
- Price
- UAMY $3.56
- ARTV $2.18
- Analyst Decision
- UAMY Strong Buy
- ARTV Strong Buy
- Analyst Count
- UAMY 4
- ARTV 7
- Target Price
- UAMY $2.90
- ARTV $20.00
- AVG Volume (30 Days)
- UAMY 5.0M
- ARTV 213.6K
- Earning Date
- UAMY 05-08-2025
- ARTV 05-08-2025
- Dividend Yield
- UAMY N/A
- ARTV N/A
- EPS Growth
- UAMY N/A
- ARTV N/A
- EPS
- UAMY N/A
- ARTV N/A
- Revenue
- UAMY $18,865,900.00
- ARTV N/A
- Revenue This Year
- UAMY $269.08
- ARTV N/A
- Revenue Next Year
- UAMY $119.31
- ARTV N/A
- P/E Ratio
- UAMY N/A
- ARTV N/A
- Revenue Growth
- UAMY 97.46
- ARTV N/A
- 52 Week Low
- UAMY $0.21
- ARTV $1.78
- 52 Week High
- UAMY $3.86
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- UAMY 61.91
- ARTV N/A
- Support Level
- UAMY $3.23
- ARTV N/A
- Resistance Level
- UAMY $3.59
- ARTV N/A
- Average True Range (ATR)
- UAMY 0.31
- ARTV 0.00
- MACD
- UAMY -0.01
- ARTV 0.00
- Stochastic Oscillator
- UAMY 67.89
- ARTV 0.00
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).